Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery

NCT04316039 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04316039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04316039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
Lead sponsor
West China Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 10, 2018
Completion date
December 31, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade glioma